Advisory Board September 24, 2024
Under a new Louisiana law, which goes into effect Oct. 1, mifepristone and misoprostol will be classified as controlled substances, a decision that healthcare providers say could negatively impact patient care.
Resource library: Women’s health
Louisiana classifies abortion drugs as controlled substances
This spring, Louisiana passed a law classifying mifepristone and misoprostol as controlled substances, making it the first state to do so. The two drugs are commonly used in pregnancy and reproductive healthcare, including for abortion.
Under the law, which goes into effect Oct. 1, a person who obtains the drugs “for her own consumption” would not face prosecution, but anyone helping them, with the exception of a healthcare provider writing or filling a valid prescription, would. Individuals...
Today's Sponsors
Today's Sponsor